BioSpace News Archive

Thrive Causemetics, a leading vegan and cruelty-free direct-to-consumer makeup and skincare company built around philanthropy, announced that it will donate 100% of its October 1st profits from thrivecausemetics.com in honor of Breast Cancer Awareness + Prevention Month.

Grupo LALA, S.A.B. de C.V., a Mexican Company focused on healthy and nutritious foods (“LALA”) (BMV “LALAB”), will host a conference call to discuss Third Quarter 2019 Results.

Christine D. Baker has joined as Chief Business Officer Roman Necina, PhD, will join as Chief Technology Officer

Grantz will focus on increasing Graminex brand recognition, by developing a more defined scientific understanding of Graminex® Flower Pollen Extract™ products.

The Public Health Agency of Canada is collaborating with provincial and territorial public health partners, the Canadian Food Inspection Agency and Health Canada to investigate an outbreak of Salmonella infections.

The Pancreatic Cancer Action Network (PanCAN), a leading patient advocacy organization, is pleased to announce that longtime corporate supporter Tempur-Pedic will launch its annual “Rest Test” program today with the goal of raising $250,000.

Medicago, a biotechnology company and global leader in the development and production of plant-derived vaccines with headquarters in Quebec City, announces today that Health Canada accepted for scientific review its New Drug Submission (NDS) for a plant-based Quadrivalent Virus-Like Particle (QVLP) influenza recombinant vaccine.

Trauma center accreditation status has been granted to one additional hospital in Pennsylvania starting November 1, 2019.

Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments to address some of the most important unmet patient needs, today announced the appointment of Steve Davis to Heron’s Board of Directors.

Senseonics Holdings, Inc. announced that it has made equity grants to new employees under its 2019 Inducement Plan in accordance with NYSE American Company Guide Section 711.